Overview

NCI Definition: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors. [1]

Significant Genes in Solid Neoplasm

ABL1 +

BCR +

BRAF +

MYC +

NF1 +

Disease Details

Synonyms
Solid Tumor, Solid tumor, NOS
Parent(s)
Neoplasm
Children
Mixed Neoplasm, Mesoblastic Nephroma, Brain Meningioma, Thyroid Gland Neoplasm, Embryonal Neoplasm, Endocrine Neoplasm, Nervous System Neoplasm, Respiratory System Neoplasm, Cerebellopontine Angle Tumor, Urinary System Neoplasm, Breast Neoplasm, Trophoblastic Neoplasm, Metastatic Neoplasm, Pre-malignant Neoplasm, Sensory System Neoplasm, Connective and Soft Tissue Neoplasm, Head and Neck Neoplasm, Malignant Solid Tumor, Skull Neoplasm, Peritoneal Neoplasm, Giant Cell Neoplasm, Cardiovascular Neoplasm, Retroperitoneal Neoplasm, Myeloma, Digestive System Neoplasm, Neuroepithelial, Perineurial, and Schwann Cell Neoplasm, Germ Cell Tumor, and Central Nervous System Neoplasm

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.